Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Malkki

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|November 20, 2014
Donor activating KIR2DS1 in leukemiaJeffrey M Venstrom, Bo Dupont, Katharine C Hsu, et al.
The New England Journal of Medicine|August 31, 2012
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1Jeffrey M Venstrom, Gianfranco Pittari, Ted A Gooley, et al.
Blood|August 30, 2007
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantationBronwen E Shaw, Theodore A Gooley, Mari Malkki, et al.
Transplantation|March 20, 2009
IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantationLi-Hui Tseng, Barry Storer, Effie Petersdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancyKatharine C Hsu, Ted Gooley, Mari Malkki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Mapping MHC-resident transplantation determinantsMari Malkki, Ted A Gooley, Mary M Horowitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2Shehnaz K Hussain, Margaret M Madeleine, Lisa G Johnson, et al.
Blood|June 3, 2020
HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantationEffie W Petersdorf, Philip Stevenson, Mats Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor TransplantationEffie W Petersdorf, Mats Bengtsson, Dianne De Santis, et al.
The Lancet. Oncology|February 21, 2012
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective studyKatharina Fleischhauer, Bronwen E Shaw, Theodore Gooley, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|November 20, 2014
Donor activating KIR2DS1 in leukemiaJeffrey M Venstrom, Bo Dupont, Katharine C Hsu, et al.
The New England Journal of Medicine|August 31, 2012
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1Jeffrey M Venstrom, Gianfranco Pittari, Ted A Gooley, et al.
Blood|August 30, 2007
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantationBronwen E Shaw, Theodore A Gooley, Mari Malkki, et al.
Transplantation|March 20, 2009
IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantationLi-Hui Tseng, Barry Storer, Effie Petersdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancyKatharine C Hsu, Ted Gooley, Mari Malkki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Mapping MHC-resident transplantation determinantsMari Malkki, Ted A Gooley, Mary M Horowitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2Shehnaz K Hussain, Margaret M Madeleine, Lisa G Johnson, et al.
Blood|June 3, 2020
HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantationEffie W Petersdorf, Philip Stevenson, Mats Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor TransplantationEffie W Petersdorf, Mats Bengtsson, Dianne De Santis, et al.
The Lancet. Oncology|February 21, 2012
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective studyKatharina Fleischhauer, Bronwen E Shaw, Theodore Gooley, et al.
Pageof 5